© 2003 BMJ Publishing Group
LETTER TO JMG
ß1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome
1 Department of Genetics and Unit INSERM 393, Hôf.pital Necker Enfants-Malades, 149 rue de Sevres, 75743 Paris Cedex 15, France
2 Department of Paediatrics, Hôf.pital Necker Enfants-Malades, 149 rue de Sevres, 75743 Paris Cedex 15, France
3 Department of Biology, Hôf.pital Necker Enfants-Malades, 149 rue de Sevres, 75743 Paris Cedex 15, France
4 Department of Toxicology, Hôf.pital Ambroise Paré, Paris, France
Correspondence to:
Correspondence to:
Professor A Munnich, Département de Génétique et Unité INSERM 393, Hôf.pital Necker Enfants-Malades, 149 rue de Sévres, 75743 Paris Cedex 15, France;
munnich@necker.fr
Keywords: Smith-Magenis syndrome; circadian rhythm; sleep; melatonin
| The first 150 words of the full text of this article appear below. |
First described by Smith et al1 in 1982, Smith-Magenis syndrome (SMS) is a contiguous gene syndrome ascribed to interstitial deletions of chromosome 17p11.2. Clinical features include infantile hypotonia, characteristic craniofacial appearance, brachydactyly, short stature, ocular anomalies, deep, hoarse voice, early speech delay, mental retardation, and behavioural disturbances.2,3 Behavioural problems include hyperactivity, attention deficit, self-injury, temper tantrums, and major sleep disturbance.4 These symptoms have a major impact on the children and their families. The diagnosis is based on high resolution karyotype analysis and fluorescence in situ hybridisation (FISH).5
Sleep disturbances occur in all cases and are predictive of maladaptive behaviour, increased by mental retardation and cognitive delay. The specific pattern of sleep disturbance in SMS includes early sleep onset, frequent awakenings, and early waking.6,7 Moreover, "sleep attacks" at the end of the day are consistent features of the disease and may represent the endogenous sleep onset of the patients. The children
This article has been cited by other articles:
-
Reardon, W., Donnai, D.
(2007). Dysmorphology demystified. Arch. Dis. Child. Fetal Neonatal Ed.
92: F225-F229
[Full Text] -
Turk, J
(2003). Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary. J. Med. Genet.
40: 793-796
[Abstract] [Full Text]
eLetters:
Read all eLetters
- Improvement of sleep disturbances and behaviour in Smith-Magenis syndrome with morning melatonin
- Jasper V Been, et al.
- J Med Genet, 7 Oct 2003 [Full text]
- Treatment of Smith-Magenis syndrome as an advanced sleep phase syndrome
- Hélène de Leersnyder, et al.
- J Med Genet, 19 Nov 2003 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
